Clinical Trial Update: A Phase II Study to Evaluate the Efficacy and Safety of SHR-1314 in Lupus Nephritis [Phase 2]

View source ↗

Summary

Phase II study investigating the efficacy and safety of SHR-1314 in lupus nephritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lupus Nephritis

Drugs mentioned

• SHR-1314 (SHR-1314)

Snippet

Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. | Conditions: Lupus Nephritis | Phase 2 | Status: UNKNOWN